115 related articles for article (PubMed ID: 17430499)
1. Limitations of the human-PBL-SCID mouse model for vaginal transmission of HIV-1.
D'Cruz OJ; Uckun FM
Am J Reprod Immunol; 2007 May; 57(5):353-60. PubMed ID: 17430499
[TBL] [Abstract][Full Text] [Related]
2. The human HIV/peripheral blood lymphocyte (PBL)-SCID mouse. A modified human PBL-SCID model for the study of HIV pathogenesis and therapy.
Boyle MJ; Connors M; Flanigan ME; Geiger SP; Ford H; Baseler M; Adelsberger J; Davey RT; Lane HC
J Immunol; 1995 Jun; 154(12):6612-23. PubMed ID: 7759895
[TBL] [Abstract][Full Text] [Related]
3. [Development of HPV16 positive cervical cancer model in the hu-PBL-SCID mouse and its immunological features].
Liang ZX; Cheng Q; Chen HZ; Xie X; Ye DF
Zhonghua Yi Xue Za Zhi; 2004 Sep; 84(17):1465-9. PubMed ID: 15500747
[TBL] [Abstract][Full Text] [Related]
4. Vaginal transmission of HIV-1 in hu-SCID mice: a new model for the evaluation of vaginal microbicides.
Di Fabio S; Giannini G; Lapenta C; Spada M; Binelli A; Germinario E; Sestili P; Belardelli F; Proietti E; Vella S
AIDS; 2001 Nov; 15(17):2231-8. PubMed ID: 11698695
[TBL] [Abstract][Full Text] [Related]
5. Pertussis toxin B-oligomer inhibits HIV infection and replication in hu-PBL-SCID mice.
Lapenta C; Spada M; Santini SM; Racca S; Dorigatti F; Poli G; Belardelli F; Alfano M
Int Immunol; 2005 Apr; 17(4):469-75. PubMed ID: 15746245
[TBL] [Abstract][Full Text] [Related]
6. Cocaine and sigma-1 receptors modulate HIV infection, chemokine receptors, and the HPA axis in the huPBL-SCID model.
Roth MD; Whittaker KM; Choi R; Tashkin DP; Baldwin GC
J Leukoc Biol; 2005 Dec; 78(6):1198-203. PubMed ID: 16204638
[TBL] [Abstract][Full Text] [Related]
7. Tetrahydrocannabinol suppresses immune function and enhances HIV replication in the huPBL-SCID mouse.
Roth MD; Tashkin DP; Whittaker KM; Choi R; Baldwin GC
Life Sci; 2005 Aug; 77(14):1711-22. PubMed ID: 15964028
[TBL] [Abstract][Full Text] [Related]
8. Interleukin-4-transgenic hu-PBL-SCID mice: a model for the screening of antiviral drugs and immunotherapeutic agents against X4 HIV-1 viruses.
Okuma K; Tanaka R; Ogura T; Ito M; Kumakura S; Yanaka M; Nishizawa M; Sugiura W; Yamamoto N; Tanaka Y
J Infect Dis; 2008 Jan; 197(1):134-41. PubMed ID: 18171296
[TBL] [Abstract][Full Text] [Related]
9. HIV-1 DNA load analysis in peripheral blood lymphocytes and monocytes from naïve and HAART-treated individuals.
Gibellini D; Borderi M; De Crignis E; Cicola R; Cimatti L; Vitone F; Chiodo F; Re MC
J Infect; 2008 Mar; 56(3):219-25. PubMed ID: 18276011
[TBL] [Abstract][Full Text] [Related]
10. Quantitative assessment of human immunodeficiency virus type 1 replication in human xenografts of acutely infected Hu-PBL-SCID mice.
Koup RA; Hesselton RM; Safrit JT; Somasundaran M; Sullivan JL
AIDS Res Hum Retroviruses; 1994 Mar; 10(3):279-84. PubMed ID: 8018388
[TBL] [Abstract][Full Text] [Related]
11. [Human peripheral blood CD4+ T-lymphocytes reconstituting severe combined immunodeficient mouse-human cell immune system and its immunological function].
Zeng QH; Wang W; Liu T; Shi Q
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2004 Oct; 29(5):513-6. PubMed ID: 16137035
[TBL] [Abstract][Full Text] [Related]
12. Selective infection of CD4+ effector memory T lymphocytes leads to preferential depletion of memory T lymphocytes in R5 HIV-1-infected humanized NOD/SCID/IL-2Rgammanull mice.
Nie C; Sato K; Misawa N; Kitayama H; Fujino H; Hiramatsu H; Heike T; Nakahata T; Tanaka Y; Ito M; Koyanagi Y
Virology; 2009 Nov; 394(1):64-72. PubMed ID: 19744686
[TBL] [Abstract][Full Text] [Related]
13. Cationized hyperimmune immunoglobulins: pharmacokinetics, toxicity evaluation and treatment of human immunodeficiency virus-infected human-peripheral blood lymphocytes-severe combined immune deficiency mice.
Pardridge WM; Kang YS; Diagne A; Zack JA
J Pharmacol Exp Ther; 1996 Jan; 276(1):246-52. PubMed ID: 8558438
[TBL] [Abstract][Full Text] [Related]
14. [Model of B immunoblastic lymphomas in the Hu-PBL-SCID mice].
Chen DQ; Bai LJ; Liu QF; Cui LX; He W; Ba DN
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2003 Jun; 25(3):294-6. PubMed ID: 12905742
[TBL] [Abstract][Full Text] [Related]
15. Comparison of 3 nucleic acid isolation methods for the quantification of HIV-1 RNA by Cobas Taqman real-time polymerase chain reaction system.
Alp A; Hascelik G
Diagn Microbiol Infect Dis; 2009 Apr; 63(4):365-71. PubMed ID: 19232859
[TBL] [Abstract][Full Text] [Related]
16. Defining antibody protection against HIV-1 transmission in Hu-PBL-SCID mice.
Koup RA; Safrit JT; Weir R; Gauduin MC
Semin Immunol; 1996 Aug; 8(4):263-8. PubMed ID: 8883150
[TBL] [Abstract][Full Text] [Related]
17. Clinical comparison of branched DNA and reverse transcriptase-PCR and nucleic acid sequence-based amplification assay for the quantitation of circulating recombinant form_BC HIV-1 RNA in plasma.
Pan P; Tao X; Zhang Q; Xing W; Sun X; Pei L; Jiang Y
AIDS; 2007 Dec; 21 Suppl 8():S27-32. PubMed ID: 18172387
[TBL] [Abstract][Full Text] [Related]
18. In situ reconstruction of humoral immune response against sperm: comparison of SCID and NOD/SCID mouse models.
Grygielska B; Kamieniczna M; Wiland E; Kurpisz M
Am J Reprod Immunol; 2009 Feb; 61(2):147-57. PubMed ID: 19143678
[TBL] [Abstract][Full Text] [Related]
19. Early events in HIV transmission through a human reconstructed vaginal mucosa.
Bouschbacher M; Bomsel M; Verronèse E; Gofflo S; Ganor Y; Dezutter-Dambuyant C; Valladeau J
AIDS; 2008 Jul; 22(11):1257-66. PubMed ID: 18580604
[TBL] [Abstract][Full Text] [Related]
20. Transmission of HIV-1 minority-resistant variants and response to first-line antiretroviral therapy.
Peuchant O; Thiébaut R; Capdepont S; Lavignolle-Aurillac V; Neau D; Morlat P; Dabis F; Fleury H; Masquelier B;
AIDS; 2008 Jul; 22(12):1417-23. PubMed ID: 18614864
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
